Oramed Pharmaceuticals
Price & Volume
Stats
See moreOpen | $2.36 |
Previous Close | $2.31 |
Day Range | $2.35-$2.36 |
52W Range | $2-$3.67 |
Market Cap | $94.5M |
Shares Short | 299,983 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | $2.7M |
Diluted EPS | $0.51 |
News
See moreYahoo Finance • last year
Oramed to Present at the 83rd American Diabetes Association Conference
Yahoo Finance • last year
Oramed Pharmaceuticals (NASDAQ:ORMP) Is In A Good Position To Deliver On Growth Plans
Yahoo Finance • 2 years ago
The past year for Oramed Pharmaceuticals (NASDAQ:ORMP) investors has not been profitable
Yahoo Finance • 2 years ago
Oramed’s oral insulin pill fails; stock is down 72%
About
CEO | Mr. Nadav Kidron Esq. |
CFO | Mr. Avraham Gabay |
Address | 1185 Avenue of the Americas, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
